osthol has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, Y; Guo, J; Li, G; Liang, S; Peng, H; Sheng, X; Wu, B; Xu, Z; Zhang, Y | 1 |
| Gao, Y; Gong, Y; Jia, T; Li, G; Li, L; Li, S; Liang, S; Liu, H; Liu, S; Ouyang, S; Shi, L; Wu, B; Xu, H; Yang, R; Yi, Z; Yuan, H; Zhang, C; Zhao, S; Zou, L | 1 |
2 other study(ies) available for osthol and Diabetic Neuropathies
| Article | Year |
|---|---|
Osthole relieves diabetics cardiac autonomic neuropathy associated with P2X3 receptor in ratstellate ganglia.
Topics: Animals; Blood Pressure; Coumarins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia; Male; Molecular Docking Simulation; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; Streptozocin | 2020 |
Osthole alleviated diabetic neuropathic pain mediated by the P2X
Topics: Analgesics; Animals; Coumarins; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Hyperalgesia; Hypoglycemic Agents; Male; Neuralgia; Pain Threshold; Purinergic P2X Receptor Antagonists; Random Allocation; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; Up-Regulation | 2018 |